Osmotic Diuretic
Pregnancy: Use with caution — osmotic effect may affect fetal fluid balance; use only for life-threatening raised ICP
Mannitol (Surgical — ICP/Osmotherapy)
Brand names: Mannitol 20%, Osmitrol
Adult dose
Dose: Raised ICP: 0.25–1 g/kg IV over 15–30 min; Renal protection (aortic surgery): 0.5 g/kg IV before aortic cross-clamp; Cerebral oedema: 1 g/kg IV
Route: IV via filter (crystallisation risk — use 5 micron in-line filter)
Frequency: Every 6–8 hours as needed (ICP); single perioperative dose (renal protection)
Max: 2 g/kg per dose; cumulative daily dose limited by serum osmolality (target gap <20 mOsm/kg)
20% mannitol = 200 g/L. Osmotic mechanism draws water from cerebral and soft tissue into intravascular space. Peak ICP effect in 15–30 min. Used in neurosurgery for brain relaxation, raised ICP from trauma/haematoma, and as renal protectant before aortic cross-clamping or during cardiac surgery.
Paediatric dose
Dose: 0.25–1 g/kg
Route: IV over 15–30 min
Frequency: Every 6 hours as needed
Max: 1 g/kg per dose
Paediatric raised ICP: 0.25–0.5 g/kg IV. Monitor serum osmolality and osmolar gap in children.
Dose adjustments
Renal
Avoid in anuric renal failure — osmotic load cannot be excreted; causes hypernatraemia and circulatory overload. Use hypertonic saline as alternative for ICP in renal failure.
Hepatic
No specific adjustment required.
Paediatric weight-based calculator
Paediatric raised ICP: 0.25–0.5 g/kg IV. Monitor serum osmolality and osmolar gap in children.
Clinical pearls
- Mannitol vs hypertonic saline for raised ICP: both effective. Hypertonic saline increasingly preferred in TBI — does not cause systemic dehydration, maintains MAP, and avoids rebound ICP. NICE NG158 (Head Injury): consider hypertonic saline as first-line if haemodynamically compromised
- Osmolar gap monitoring: measure serum osmolality before repeat doses; osmolar gap = measured − calculated osmolality; target gap <20 mOsm/kg to avoid mannitol accumulation and renal toxicity
- Neurosurgical brain relaxation: mannitol infused during craniotomy creates slack brain — improves surgical access. Often combined with head elevation (30°), moderate hyperventilation (PaCO2 4.0–4.5), and positioning
Contraindications
- Anuria/severe oliguria (accumulation causes circulatory overload)
- Severe pulmonary oedema
- Severe dehydration
- Active intracranial haemorrhage (relative — debate in trauma)
Side effects
- Initial plasma volume expansion (can worsen cardiac failure before diuresis)
- Hypernatraemia
- Hypovolaemia (excessive diuresis)
- Rebound cerebral oedema (if osmolar gap allowed to fall rapidly)
- Crystallisation in IV lines (use filter)
Interactions
- Diuretics (additive dehydration and electrolyte loss)
- Lithium (increased lithium excretion — monitor levels)
- Cisplatin (additive nephrotoxicity)
Monitoring
- Serum osmolality and osmolar gap (before repeat doses)
- Serum electrolytes (Na, K)
- Urine output (oliguria = dose omit)
- ICP monitoring if invasive bolt in situ
- Fluid balance
Reference: BNFc; BNF 90; NICE NG158 (Head Injury); Neurocritical Care Society Guidelines 2023; ESA Perioperative Guidelines; BNFc. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- POSSUM Score for Surgical Morbidity and Mortality · Perioperative Risk
- SORT (Surgical Outcome Risk Tool) · Perioperative Risk
- ASA Physical Status Classification · Perioperative Risk
- Caprini Score for VTE Risk (2005) · VTE Risk
- EuroSCORE II · Surgical Risk
- Thakar Score for AKI after Cardiac Surgery · Surgical Risk
Pathways
- Major Trauma — Primary Survey (ATLS) · ATLS 10th Edition; JRCALC; NICE NG39
- Major Haemorrhage / Massive Transfusion · BCSH; RCOA; RCEM; RCS — BCSH Guidelines
- Lower Gastrointestinal Bleed · NICE; BSG; ACPGBI — Commissioning Guide
- Acute Pancreatitis · NICE; IAP/APA; ACPGBI — CG104
- Faecal Peritonitis · ASGBI; RCS — Best Practice
- Acute Compartment Syndrome · BAPRAS; BOA; RCS — Best Practice